The comparison of mutation-based biomarkers for early-stage and advanced-stage non-small cell lung caner.

e21176Background: In recent years, immune checkpoint inhibitors have shown promise in the treatment of advanced-stage non-small cell lung cancer (NSCLC), more and more clinical studies have proved ...